SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Lifesciences - Quaterly Results

09 Aug 2022 Evaluate
The revenue for the June 2022 quarter is pegged at Rs. 804.53 millions, about 9.87% up against Rs. 732.25 millions recorded during the year-ago period.An average growth of 41.72% was recorded for the quarter ended June 2022 to Rs. 41.07  millions from Rs. 28.98 millions.OP of the company witnessed a marginal growth to 91.97 millions from 71.44 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 804.53 732.25 9.87 804.53 732.25 9.87 3456.28 2602.56 32.80
Other Income 3.00 0.44 581.82 3.00 0.44 581.82 15.36 13.33 15.23
PBIDT 91.97 71.44 28.74 91.97 71.44 28.74 329.00 310.68 5.90
Interest 11.81 10.69 10.48 11.81 10.69 10.48 46.25 45.00 2.78
PBDT 80.16 60.75 31.95 80.16 60.75 31.95 409.67 265.68 54.20
Depreciation 19.89 19.67 1.12 19.89 19.67 1.12 79.90 72.13 10.77
PBT 60.27 41.08 46.71 60.27 41.08 46.71 329.77 193.55 70.38
TAX 19.20 12.10 58.68 19.20 12.10 58.68 75.96 61.86 22.79
Deferred Tax -0.80 -0.10 700.00 -0.80 -0.10 700.00 0.36 11.59 -96.89
PAT 41.07 28.98 41.72 41.07 28.98 41.72 253.81 131.69 92.73
Equity 30.23 30.23 0.00 30.23 30.23 0.00 30.23 30.23 0.00
PBIDTM(%) 11.43 9.76 17.17 11.43 9.76 17.17 9.52 11.94 -20.26

Haleos Labs Share Price

1339.95 39.95 (3.07%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×